China pharma M&A heats up with Luye deal

Luye Pharma Group has agreed to buy a subsidiary of Swiss counterpart Acino, becoming the latest Chinese healthcare company to look overseas for expansion.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES